| Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis G Ianiro, M Maida, J Burisch, C Simonelli, G Hold, M Ventimiglia, ... United European Gastroenterology Journal 6 (8), 1232-1244, 2018 | 164 | 2018 |
| The SPOSIB SB2 sicilian cohort: safety and effectiveness of infliximab biosimilar SB2 in inflammatory bowel diseases, including multiple switches FS Macaluso, W Fries, A Viola, A Centritto, M Cappello, E Giuffrida, ... Inflammatory Bowel Diseases 27 (2), 182-189, 2021 | 41 | 2021 |
| Effectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies FS Macaluso, M Maida, M Ventimiglia, M Cottone, A Orlando Expert Opinion on Biological Therapy 20 (2), 193-203, 2020 | 41 | 2020 |
| The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases FS Macaluso, R Orlando, W Fries, M Scolaro, A Magnano, D Pluchino, ... Digestive and Liver Disease 50 (7), 675-681, 2018 | 39 | 2018 |
| Effectiveness of very low-volume preparation for colonoscopy: A prospective, multicenter observational study M Maida, E Sinagra, GC Morreale, S Sferrazza, G Scalisi, D Schillaci, ... World Journal of Gastroenterology 26 (16), 1950, 2020 | 38 | 2020 |
| Bioimpedance vector references need to be period-specific for assessing body composition and cellular health in elite soccer players: A brief report T Bongiovanni, G Mascherini, F Genovesi, G Pasta, FM Iaia, A Trecroci, ... Journal of functional morphology and kinesiology 5 (4), 73, 2020 | 32 | 2020 |
| Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience FS Macaluso, S Renna, M Maida, M Dimarco, C Sapienza, M Affronti, ... Scandinavian journal of gastroenterology 52 (9), 981-987, 2017 | 31 | 2017 |
| A propensity score-matched comparison of infliximab and adalimumab in tumour necrosis factor-α inhibitor-naïve and non-naïve patients with Crohn’s disease: real-life data from … FS Macaluso, W Fries, AC Privitera, M Cappello, S Siringo, G Inserra, ... Journal of Crohn's and Colitis 13 (2), 209-217, 2019 | 29 | 2019 |
| Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study FS Macaluso, W Fries, S Renna, A Viola, M Muscianisi, M Cappello, ... United European gastroenterology journal 8 (9), 1045-1055, 2020 | 25 | 2020 |
| Persistence on anti-tumour necrosis factor therapy in older patients with inflammatory bowel disease compared with younger patients: data from the Sicilian Network for … S Porcari, A Viola, A Orlando, AC Privitera, C Ferracane, M Cappello, ... Drugs & Aging 37, 383-392, 2020 | 20 | 2020 |
| A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis S Renna, F Mocciaro, M Ventimiglia, R Orlando, FS Macaluso, ... Digestive and Liver Disease 50 (12), 1292-1298, 2018 | 20 | 2018 |
| The addition of an immunosuppressant after loss of response to anti-TNFα monotherapy in inflammatory bowel disease: a 2-year study FS Macaluso, C Sapienza, M Ventimiglia, S Renna, G Rizzuto, R Orlando, ... Inflammatory Bowel Diseases 24 (2), 394-401, 2018 | 19 | 2018 |
| SPOSAB ABP 501: a Sicilian prospective observational study of patients with inflammatory bowel disease treated with adalimumab biosimilar ABP 501 FS Macaluso, M Cappello, A Busacca, W Fries, A Viola, G Costantino, ... Journal of Gastroenterology and Hepatology 36 (11), 3041-3049, 2021 | 17 | 2021 |
| A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease FS Macaluso, M Ventimiglia, W Fries, A Viola, A Sitibondo, M Cappello, ... Journal of Gastroenterology and Hepatology 36 (1), 105-111, 2021 | 17 | 2021 |
| Factors affecting clinical and endoscopic outcomes of placebo arm in trials of biologics and small molecule drugs in ulcerative colitis: a meta-analysis FS Macaluso, M Maida, M Ventimiglia, S Renna, M Cottone, A Orlando Inflammatory Bowel Diseases 25 (6), 987-997, 2019 | 17 | 2019 |
| A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis FS Macaluso, M Ventimiglia, W Fries, A Viola, M Cappello, B Scrivo, ... Digestive and Liver Disease 52 (12), 1461-1466, 2020 | 16 | 2020 |
| Physicians’ knowledge and application of immunization strategies in patients with inflammatory bowel disease: a survey of the Italian Group for the Study of Inflammatory Bowel … FS Macaluso, G Mazzola, M Ventimiglia, P Alvisi, S Renna, L Adamoli, ... Digestion 101 (4), 433-440, 2020 | 16 | 2020 |
| Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials M Maida, FS Macaluso, S Sferrazza, M Ventimiglia, E Sinagra Digestive and Liver Disease 52 (8), 833-839, 2020 | 14 | 2020 |
| Health-related quality of life and home enteral nutrition in children with neurological impairment: report from a multicenter survey V Dipasquale, M Ventimiglia, SMC Gramaglia, B Parma, C Funari, ... Nutrients 11 (12), 2968, 2019 | 14 | 2019 |
| Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort FS Macaluso, C Sapienza, M Ventimiglia, S Renna, M Cottone, A Orlando Scandinavian Journal of Gastroenterology 54 (9), 1102-1106, 2019 | 14 | 2019 |
